The report " Cell and Gene Therapy Market by Therapy Type (Cell Therapy (CAR-T Cell Therapy, Stem Cell Therapy, and Tumor Infiltrating Lymphocyte (TIL) Therapy), Gene Therapy (Gene Augmentation, Gene Editing, and Gene Slicing)), by Therapeutic Area (Oncology, Rare Disease, Neurological Disorders, Cardiovascular Diseases, and Others), by Delivery Method (In-Vivo, and Ex-Vivo), by End User (Hospitals and Specialty Clinics, Academic Research Institutions, and Biotechnology and Pharmaceutical Companies)- Global Forecasts to 2030"